analysts Estimates and Ratings: Horizon Pharma plc (NASDAQ:HZNP)


Horizon Pharma plc (NASDAQ:HZNP) reported the earnings of $0.7/Share in the last quarter where the estimated EPS by analysts was $0.63/share. The difference between the expected and actual EPS was $0.07/share, which represents an Earnings surprise of 11.1%.

In case of Revenue Estimates, 10 analysts have provided their consensus Average Revenue Estimates for Horizon Pharma plc as 307.53 Million. According to these analysts, the Low Revenue Estimate for Horizon Pharma plc is 271.6 Million and the High Revenue Estimate is 319.8 Million. The company had Year Ago Sales of 244.54 Million.

Some buy side analysts are also providing their Analysis on Horizon Pharma plc, where 3 analysts have rated the stock as Strong buy, 7 analysts have given a Buy signal, 2 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 12 Analysts reported that the Price Target for Horizon Pharma plc might touch $45 high while the Average Price Target and Low price Target is $30 and $21 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Horizon Pharma plc got Upgrade on 28-Nov-16 where investment firm Citigroup Upgrade the stock from Neutral to Buy.

Horizon Pharma plc closed its last trading session at $21.05 with the loss of -5.94%. The Market Capitalization of the company stands at 3.19 Billion. The Company has 52-week high of $23.44 and 52-week low of $13.05. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 1.5% where SMA50 and SMA200 are 5.2% and 10.53% respectively. The Company Touched its 52-Week High on Aug 15, 2016 and 52-Week Low on May 6, 2016.

The Relative Volume of the company is 1.7 and Average Volume (3 months) is 3.03 million. Horizon Pharma plc P/E (price to earnings) ratio is 0 and Forward P/E ratio of 7.93.

The company shows its Return on Assets (ROA) value of -0.4%. The Return on Equity (ROE) value stands at -0.9%. While it’s Return on Investment (ROI) value is 3%.

While looking at the Stock’s Performance, Horizon Pharma plc currently shows a Weekly Performance of -6.6%, where Monthly Performance is 18.42%, Quarterly performance is 5.32%, 6 Months performance is 10.68% and yearly performance percentage is -7.04%. Year to Date performance value (YTD perf) value is -8.63%. The Stock currently has a Weekly Volatility of 5.17% and Monthly Volatility of 5.65%.